AMX-0318

N/A

Report date: 2026/01/14 16:53:59
NME

Base Information

Drug NameAMX-0318
Drug Alias NameGLP-1R antagonist (Gubra)AMX0318AMX-0318
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionGlucagon-like peptide 1 receptor antagonists
TargetsGlucagon-like peptide 1 receptor
Therapy Area/IndicationsPost-bariatric Hypoglycemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryDenmark
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGubra A/SAmylyx Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesGubra A/SAmylyx Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsPost-bariatric Hypoglycemia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A